Tag: anti-obesity drugs

Global Markets

JPM Healthcare Conference 2026: Pharma Outlook

The JPM Healthcare Conference kicks off next week, and pharma leaders are ready to reveal their 2026 strategies. From massive...

09/01/2026

10 views

Read More

Market News

Eli Lilly Boost and 2026 Market Rotation Insights

The stock market is kicking off 2026 with broader gains than last year, and some forgotten names are suddenly shining....

06/01/2026

7 views

Read More

Market News

Top Stocks Moving Midday: Novo Nordisk Leads Surge

Midday trading on December 23 saw massive action: Novo Nordisk soared 8% after a groundbreaking FDA approval for its oral...

23/12/2025

4 views

Read More

Growth Picks

Amgen Stock: Emerging Obesity Powerhouse and Options Trade Ideas

Amgen is quietly reshaping itself around obesity treatments and rare diseases, with MariTide offering huge upside potential. But with legacy...

17/12/2025

5 views

Read More

Global Companies

Eli Lilly Bets $6 Billion on Alabama Plant for Obesity Drugs

Eli Lilly just dropped $6 billion on a massive new plant in Alabama — and the main reason is one...

09/12/2025

9 views

Read More

Global Companies

Pfizer Bets Big on Oral Obesity Pill in $2.1B China Deal

Pfizer just dropped $150M upfront (and up to $2.1B total) on a Chinese company's oral obesity pill. After losing the...

09/12/2025

8 views

Read More

Growth Picks

Wave Life Sciences Stock Doubles: 57% More Upside Ahead?

A tiny Singapore biotech just exploded 147% in a single session after revealing an obesity shot that melts fat but...

09/12/2025

5 views

Read More

Market News

Top Stocks Soaring Midday: Biotech, AI, Media Deals

Monday midday trading was absolute chaos in the best way: one little-known biotech more than doubled, takeover rumors worth $11...

08/12/2025

4 views

Read More

Global Companies

Novo Nordisk Abandons Metsera Bid: Investor Impacts

Novo Nordisk steps back from a heated $10B battle for Metsera, leaving Pfizer victorious. But is this savvy discipline or...

10/11/2025

7 views

Read More

Global Companies

Novo Nordisk Past Peak Uncertainty? Q3 Preview

Novo Nordisk faces Q3 earnings with new CEO, slumping sales, and fierce US rivals in obesity drugs. Berenberg says peak...

02/11/2025

7 views

Read More